During the past decade, Centre Marie Curie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Marie Curie" #1 sponsor was "UNICANCER" with 4 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Centre Francois Baclesse" with 1 trials sponsored, "Centre Leon Berard" with 1 trials sponsored and "Institut Claudius Regaud" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Marie Curie" #1 collaborator was "National Cancer Institute, France" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Ferring Pharmaceuticals" with 1 trials as a collaborator and "GETUG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Centre Marie Curie" are "Metastatic Breast Cancer" (2 trials), "Adenocarcinoma of Prostate" (1 trials), "Bone Metastases" (1 trials), "Breast Cancer" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Centre Marie Curie" in a lesser frequency.

Most popular intervention types in "Centre Marie Curie" are "Radiation" (7 trials), "Drug" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AFATINIB" (1 trials), "Accelerated partial breast irradiation" (1 trials), "Degarelix" (1 trials), "Experimental arm" (1 trials) and "Pelvic Radiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Marie Curie" are 6 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Marie Curie". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centre Marie Curie, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Marie Curie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".